(VRTX)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

VRTX Insider Transactions

Transaction Date
(SEC Report )		 Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2023-03-24 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 49,611 S-Sale D 1,768 305.38 539,911.84
2023-03-17 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 53,019 S-Sale D 360 294.52 106,027.20
2023-03-17 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 52,235 S-Sale D 784 295.43 231,617.12
2023-03-17 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 51,995 S-Sale D 240 296.30 71,112.00
2023-03-17 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 51,635 S-Sale D 360 298.09 107,312.40
2023-03-17 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 51,395 S-Sale D 240 299.58 71,899.20
2023-03-17 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 51,379 S-Sale D 16 301.13 4,818.08
2023-03-16 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 49,532 S-Sale D 2,482 300.54 745,940.28
2023-03-16 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 49,268 S-Sale D 264 301.07 79,482.48
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 57,772 S-Sale D 361 286.64 103,477.04
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 57,257 S-Sale D 515 287.83 148,232.45
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 56,930 S-Sale D 327 288.91 94,473.57
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 56,900 S-Sale D 30 289.44 8,683.20
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 56,359 S-Sale D 541 291.47 157,685.27
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 56,174 S-Sale D 185 292.68 54,145.80
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 56,147 S-Sale D 27 293.61 7,927.47
2023-03-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 56,045 S-Sale D 102 294.94 30,083.88
2023-03-13 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 56,021 S-Sale D 24 288.31 6,919.44
2023-03-13 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 55,061 S-Sale D 420 292.41 122,812.20
2023-03-13 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 54,448 S-Sale D 1,153 293.35 338,232.55
2023-03-13 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 53,733 S-Sale D 715 294.52 210,581.80
2023-03-13 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 53,441 S-Sale D 292 295.89 86,399.88
2023-03-13 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 53,379 S-Sale D 62 296.77 18,399.74
2023-02-24 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 58,133 F-InKind D 3,308 289.12 956,408.96
2023-02-24 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 57,159 F-InKind D 3,308 289.12 956,408.96
2023-02-27 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 56,876 S-Sale D 283 287.20 81,277.60
2023-02-27 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 56,825 S-Sale D 51 288.33 14,704.83
2023-02-27 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 56,805 S-Sale D 20 289.29 5,785.80
2023-02-24 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 52,014 F-InKind D 3,970 289.12 1,147,806.40
2023-02-24 Sachdev Amit officer: EVP, Chief Patient Officer 66,518 F-InKind D 2,468 289.12 713,548.16
2023-02-24 LEIDEN JEFFREY M director, officer: Executive Chairman 48,349 F-InKind D 13,730 289.12 3,969,617.60
2023-02-24 Kewalramani Reshma director, officer: CEO & President 129,969 F-InKind D 9,386 289.12 2,713,680.32
2023-02-24 Bozic Carmen officer: EVP and CMO 63,207 F-InKind D 3,308 289.12 956,408.96
2023-02-24 Arbuckle Stuart A officer: EVP, COO 61,590 F-InKind D 4,714 289.12 1,362,911.68
2023-02-27 Arbuckle Stuart A officer: EVP, COO 57,756 S-Sale D 3,834 287.16 1,100,971.44
2023-02-27 Arbuckle Stuart A officer: EVP, COO 57,356 S-Sale D 400 287.59 115,036.00
2023-02-27 Arbuckle Stuart A officer: EVP, COO 56,556 S-Sale D 800 288.92 231,136.00
2023-02-24 Ambrose Kristen officer: SVP & Chief Accounting Officer 8,510 F-InKind D 502 289.12 145,138.24
2023-02-27 Ambrose Kristen officer: SVP & Chief Accounting Officer 7,528 S-Sale D 982 287.25 282,079.50
2023-02-27 Ambrose Kristen officer: SVP & Chief Accounting Officer 7,345 S-Sale D 183 288.68 52,828.44
2023-02-27 Ambrose Kristen officer: SVP & Chief Accounting Officer 7,303 S-Sale D 42 289.63 12,164.46
2023-02-24 ALTSHULER DAVID officer: EVP, Global Research and CSO 36,276 F-InKind D 3,970 289.12 1,147,806.40
2023-02-27 ALTSHULER DAVID officer: EVP, Global Research and CSO 32,640 S-Sale D 3,636 287.23 1,044,368.28
2023-02-27 ALTSHULER DAVID officer: EVP, Global Research and CSO 32,340 S-Sale D 300 288.74 86,622.00
2023-02-27 ALTSHULER DAVID officer: EVP, Global Research and CSO 32,038 S-Sale D 302 289.60 87,459.20
2023-02-22 Arbuckle Stuart A officer: EVP, COO 68,576 S-Sale D 129 291.84 37,647.36
2023-02-22 Arbuckle Stuart A officer: EVP, COO 68,276 S-Sale D 300 292.86 87,858.00
2023-02-22 Arbuckle Stuart A officer: EVP, COO 66,898 S-Sale D 1,378 294.29 405,531.62
2023-02-22 Arbuckle Stuart A officer: EVP, COO 66,504 S-Sale D 394 295.38 116,379.72
2023-02-22 Arbuckle Stuart A officer: EVP, COO 66,304 S-Sale D 200 296.31 59,262.00
2023-02-17 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 61,441 F-InKind D 3,750 292.85 1,098,187.50
2023-02-17 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 60,947 F-InKind D 4,498 292.85 1,317,239.30
2023-02-21 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 60,943 S-Sale D 4 291.01 1,164.04
2023-02-21 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 60,798 S-Sale D 145 292.85 42,463.25
2023-02-21 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 60,591 S-Sale D 207 293.83 60,822.81
2023-02-21 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 60,467 S-Sale D 124 294.77 36,551.48
2023-02-17 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 55,984 F-InKind D 3,750 292.85 1,098,187.50
2023-02-17 Sachdev Amit officer: EVP, Chief Patient Officer 68,986 F-InKind D 3,498 292.85 1,024,389.30
2023-02-17 Kewalramani Reshma director, officer: CEO & President 139,355 F-InKind D 9,359 292.85 2,740,783.15
2023-02-17 Bozic Carmen officer: EVP and CMO 66,515 F-InKind D 3,750 292.85 1,098,187.50
2023-02-17 Arbuckle Stuart A officer: EVP, COO 71,107 F-InKind D 4,498 292.85 1,317,239.30
2023-02-21 Arbuckle Stuart A officer: EVP, COO 71,086 S-Sale D 21 291.01 6,111.21
2023-02-21 Arbuckle Stuart A officer: EVP, COO 70,541 S-Sale D 545 292.77 159,559.65
2023-02-21 Arbuckle Stuart A officer: EVP, COO 69,441 S-Sale D 1,100 293.74 323,114.00
2023-02-21 Arbuckle Stuart A officer: EVP, COO 68,705 S-Sale D 736 294.58 216,810.88
2023-02-17 ALTSHULER DAVID officer: EVP, Global Research and CSO 44,248 F-InKind D 3,750 292.85 1,098,187.50
2023-02-21 ALTSHULER DAVID officer: EVP, Global Research and CSO 44,212 S-Sale D 36 291.01 10,476.36
2023-02-21 ALTSHULER DAVID officer: EVP, Global Research and CSO 42,989 S-Sale D 1,223 292.76 358,045.48
2023-02-21 ALTSHULER DAVID officer: EVP, Global Research and CSO 41,146 S-Sale D 1,843 294.03 541,897.29
2023-02-21 ALTSHULER DAVID officer: EVP, Global Research and CSO 40,246 S-Sale D 900 294.73 265,257.00
2023-02-14 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,694 S-Sale D 71 295.89 21,008.19
2023-02-14 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,674 S-Sale D 20 296.48 5,929.60
2023-02-14 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,631 S-Sale D 43 297.98 12,813.14
2023-02-14 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,496 S-Sale D 135 299.60 40,446.00
2023-02-14 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,445 S-Sale D 51 300.58 15,329.58
2023-02-14 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 60,013 S-Sale D 1,902 300.29 571,151.58
2023-02-14 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 59,734 S-Sale D 279 301.11 84,009.69
2023-02-14 Arbuckle Stuart A officer: EVP, COO 81,203 S-Sale D 800 295.84 236,672.00
2023-02-14 Arbuckle Stuart A officer: EVP, COO 80,302 S-Sale D 901 296.85 267,461.85
2023-02-14 Arbuckle Stuart A officer: EVP, COO 79,742 S-Sale D 560 298.14 166,958.40
2023-02-14 Arbuckle Stuart A officer: EVP, COO 77,739 S-Sale D 2,003 299.13 599,157.39
2023-02-14 Arbuckle Stuart A officer: EVP, COO 76,005 S-Sale D 1,734 300.09 520,356.06
2023-02-14 Arbuckle Stuart A officer: EVP, COO 75,605 S-Sale D 400 300.89 120,356.00
2023-02-14 ALTSHULER DAVID officer: EVP, Global Research and CSO 53,596 S-Sale D 800 295.79 236,632.00
2023-02-14 ALTSHULER DAVID officer: EVP, Global Research and CSO 52,754 S-Sale D 842 296.85 249,947.70
2023-02-14 ALTSHULER DAVID officer: EVP, Global Research and CSO 52,359 S-Sale D 395 297.97 117,698.15
2023-02-14 ALTSHULER DAVID officer: EVP, Global Research and CSO 50,194 S-Sale D 2,165 299.08 647,508.20
2023-02-14 ALTSHULER DAVID officer: EVP, Global Research and CSO 48,306 S-Sale D 1,888 300.11 566,607.68
2023-02-14 ALTSHULER DAVID officer: EVP, Global Research and CSO 47,998 S-Sale D 308 301.02 92,714.16
2023-02-10 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 70,183 F-InKind D 2,707 294.33 796,751.31
2023-02-13 WAGNER CHARLES F JR officer: EVP & Chief Financial Officer 65,191 F-InKind D 4,992 298.26 1,488,913.92
2023-02-10 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 69,035 F-InKind D 1,377 294.33 405,292.41
2023-02-13 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 66,040 F-InKind D 2,995 298.26 893,288.70
2023-02-13 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 66,038 S-Sale D 2 295.84 591.68
2023-02-13 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,960 S-Sale D 78 298.11 23,252.58
2023-02-13 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,840 S-Sale D 120 298.98 35,877.60
2023-02-13 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,776 S-Sale D 64 299.88 19,192.32
2023-02-13 Tatsis Ourania officer: EVP, Chief Reg. & Quality Off. 65,765 S-Sale D 11 300.79 3,308.69
2023-02-10 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 66,368 F-InKind D 902 294.33 265,485.66
2023-02-13 Sanna Bastiano officer: EVP, Cell & Genetic Therapies 62,028 F-InKind D 4,340 298.26 1,294,448.40

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.